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Abstract
Simple organic molecules (SOM) based on bis(haloBODIPY) are shown to enable circularly 
polarized luminescence (CPL) conforming a new structural design for technologically-valuable 
CPL-SOMs. The established design comprises, all-in-one, synthetic accessibility, labile helicity, 
possibility of reversing the handedness of the circularly polarized emission and reactive functional 
groups, making it unique and attractive as advantageous platform for the development of smart 
CPL-SOMs.
Graphical abstract
Correspondence to: Santiago de la Moya, santmoya@ucm.es.
Supporting information for this article is given via a link at the end of the document.
HHS Public Access
Author manuscript
Chemistry. Author manuscript; available in PMC 2017 June 20.
Published in final edited form as:
Chemistry. 2016 June 20; 22(26): 8805–8808. doi:10.1002/chem.201601463.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A new structural design for CPL-SOMs comprising, all-in-one, synthetic accessibility, capacity for 
reversing the polarization handedness, helical lability and reactive functional groups making 
possible photophysics modulation is established.
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Circularly polarized luminescence (CPL) is a chiroptical phenomenon consisting of the 
differential emission of right and left circularly polarized lights by chiral systems 
(molecules, ionic pairs, polymers, metal complexes, supramolecular aggregates, etc.).[1] The 
interest of CPL is due to the resolution provided by the circular polarization of the light, 
which allows the development of smarter photonic materials for useful technologies, such as 
3D displaying,[2] information storage and processing,[3] including high-security chiroptical 
cryptography,[3c] communication of spin information (spintronics-based devices),[4] or 
bioimaging (e.g, ellipsometry-based tomography).[5] Moreover, circularly polarized light can 
be used to promote asymmetric photochemistry,[6] to control the morphology in 
nanomaterials,[7] or to detect chiral environments (chiral sensing).[8] All these characteristics 
make CPL valuable for the development of envisaged advanced photonic technologies (e.g., 
CPL microscopy).[9] Besides, but not less important, spectroscopy based on CPL is an 
indispensable source of information to know chirality factors in luminescent excited 
states.[1b,10]
The level of CPL is quantified by the luminescence dissymmetry factor, glum,[1b,11] whose 
values stand between −2 and +2 (completely right and left circularly polarized emission, 
respectively). Among the well-established chiral systems enabling CPL, mainly 
photoluminescent chiral lanthanide complexes with |glum| values typically into the 0.05–0.5 
range,[1d,e,9a,10c,12] those based on simple (small, non-polymeric and non-aggregated) 
organic molecules, CPL-SOMs, have attracted considerable attention during the last five 
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years.[13,14] This is due to the enormous technological potential of these molecules to 
develop future advanced photonic (chiroptical) materials, mainly due to properties 
associated to the small size, which makes them interesting for the development of 
physiological CPL applications, as well as to their excellent organic-solvent solubility, 
which makes them valuable for the development of CPL-active dye-doped inclusion 
materials.[13a]
However, CPL-SOMs are rare, exhibit very small levels of circular polarization (|glum| 
typically into the 10−5–10−3 range), and are restricted to a small number of chiral designs, 
which usually demand highly inefficient synthetic routes (racemate resolution or complex 
asymmetric processes are typically involved).[13a] Additionally, in most cases, the best glum 
values are not coincident with the best emission efficiencies, or with the easiest synthetic 
procedures.[13] Hence, new structural designs for CPL-SOMs, combining together CPL 
activity, emission efficiency and synthetic accessibility (allowing future cost-effective 
materials) are required.
Helicity has been demonstrated to be a privileged structural motive to achieve CPL in 
SOMs.[13a] In this sense, significant glum values have been reported for several CPL-SOMs 
having helical chirality (mainly helicenes).[13a,14] However, with the exception of scarce 
cases (helicene-like molecules),[14b] the distortion of the involved helicene chromophore, 
which is associated to the enhanced CPL activity, usually spoils the emission efficiency as 
well.[13a] Furthermore, the enantiopure preparation of these CPL-SOMs is not 
straightforward in most cases.[13a,14]
Regarding helicity and easily accessible SOMs, we have previously reported the capacity of 
(R,R)-1 and (S,S)-1 to adopt a self-induced preferential helical conformation in chloroform 
solution (P for the former, M for the latter; see Figure 1), leading to a strong and clearly 
bisignated visible (Vis) circular dichroism, which is due to the chirally-perturbed exciton-
coupled absorption of the involved identical BODIPY (4,4-difluoro-4-bora-3a,4a-diaza-s-
indacene) chromophores.[15] It must be noted here that, despite of the recognized importance 
of the BODIPY dyes in photonics, the study of chirality features in BODIPYs is still 
scarce,[13a,15–17] and chirally-perturbed BODIPY chromophores enabling CPL 
unusual.[13a,17]
This chiroptical behaviour of (R,R)-1 and (S,S)-1 at their ground state, joined to their helical 
character and synthetic accessibility, prompted us to investigate their unknown capacity to 
enable CPL, directed to the possibility of conforming a new model for CPL-SOMs on the 
basis of their peculiar structure which combines advantageous properties. The present 
communication reports the results of such investigation, which has been focused in studying 
known molecules 1 in comparison with related new molecules 2, demonstrating that these 
easily-accessible molecules are not only able to display good levels of CPL, but also to 
exhibit unprecedented capacity for reversing the polarization handedness of the CPL 
emission by a simple structural change.
Known (R,R)-1 and (S,S)-1 were straightforward obtained in a single synthetic step, by 
treating accessible 3,5-dichloro-8-(4-methylphenyl)BODIPY[18] with the corresponding 
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commercial enantiopure C2-symmetric 1,2-diphenylethan-1,2-diamine, as described 
previously by us (isolated yield ca. 50%),[15] and their unknown CPL behaviour investigated 
in chloroform solution (ca. 10−3 M).
Satisfactorily, circularly polarized emission was detected from (R,R)-1 and (S,S)-1 upon 
exciting the BODIPY chromophores with Vis light (Figure 2, left plots). This chiroptical 
activity shows that the inherently achiral BODIPY chromophores are efficiently perturbed 
by the chiral helical structure in which they are embedded, not only at the ground state, as it 
was previously shown by CD spectroscopy,[15] but also at the luminescent excited state.
The recorded CPL spectra for both enantiomers were virtually mirror images, showing 
maxima matching with the maximum Vis emission of the BODIPY chromophores (λ ca. 
570 nm; see Figure 2, left plots). It must be noted that the small values usually found for the 
CPL activity, mainly for organic chromophores, make the CPL plots highly noisy in most of 
the cases.[1–10,12,19]. Although the determined |glum| values are small, almost opposite CPL 
signals (see Figure 2, left) with maximum glum values of ca. +0.001 and −0.001 were 
measured for each enantiomer, (R,R)-1 and (S,S)-1, respectively. These results also confirm 
that the constructed helical architecture, despite its lability, is indeed able to produce the 
searched luminescent phenomenon in solution, since the emitted light is equally polarized in 
opposite directions by each enantiomer.
In order to test the workability of this new helically labile design for achieving CPL in 
SOMs, we synthesized (R,R)-2 and (S,S)-2, as oxygenated analogues of (R,R)-1 and (S,S)-1, 
respectively (Figure 1). For this purpose, we conducted a synthetic procedure similar to that 
used for enantiomers 1,[15] but employing enantiopure diols instead of diamines (isolated 
yield ca. 60%; see Figure S1 and experimental details in SI).
The fluorescence signatures of (R,R)-2 and (S,S)-2 in chloroform solution (ca. 5·10−6) were 
similar to those measured for (R,R)-1 and (S,S)-1 in the same conditions (fluorescence 
quantum yields ca. 15%; see Table S1 and Figure S2 in SI), displaying also similarly strong 
Vis CD signals (Figure S3 in SI). Interestingly, the signs of the CD Cotton effects remained 
unchanged for molecules having the same absolute configuration (e.g., for the strongest Vis 
CD signal: negative for the R,R enantiomers, positive for the S,S ones; see Figure S3 in SI). 
Besides, the optical rotations displayed by enantiomers 2 in chloroform solution were huge (|
[α]D20| ca. 3000; see SI), as those measured for enantiomers 1 in the same experimental 
conditions,[15] the rotation signs coinciding, too: the R,R isomers are levogyre in both cases, 
whereas the S,S ones are dextrogyre. All these results suggest that oxygenated enantiomers 2 
adopt an helical conformation in chloroform solution similar to that demonstrated previously 
for nitrogenated 1 (see Figure 1), and with the same preferential helical configuration, too 
(i.e., P for the R,R enantiomers, and M for the S,S ones).
Simulation of high level of theory (PCM-B3LYP/6-31+g*; see SI for details) on the 
structure of both enantiomers of 1 and 2 agrees with our previous computational data of 
lower level conducted on 1,[15] confirming that both molecules adopt the same helical 
conformation in chloroform solution, regardless the involved spacer heteroatoms, and also 
predicting the corresponding CD spectra (TD-PCM-B3LYP/6-31+g*; see Figures S4–S5 in 
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SI). Therefore, it should be expected that enantiomers 2 will also enable Vis CPL in solution 
upon Vis irradiation.
Indeed, a CPL behaviour similar to that exhibited by enantiomers 1 in chloroform solution 
was found for enantiomers 2. Thus, upon exciting the BODIPY chromophores of (R,R)-2 
and (S,S)-2 with Vis light, almost mirror CPL spectra were recorded, with maxima matching 
the maximum emission of the said chromophores (λ ca. 550 nm; see Figure 2, right plots), 
and affording |glum| values almost identical to those measured for enantiomers 1 (ca. 0.001). 
Strikingly, while nitrogenated (R,R)-1 emits preferentially left circularly polarized light 
(maximum glum = +0.001), oxygenated (R,R)-2 preferentially emits right circularly 
polarized light (maximum glum = −0.001), despite the fact that their absolute configuration is 
the same (see Figure 2). The same behaviour, but sign opposite, was observed for the S,S 
couple (i.e., negative glum for (S,S)-1, positive for (S,S)-2).
The found CPL reversal is very interesting, since the establishment of ways for the 
modulation of the circular handedness, by structural changes different to the inversion of the 
absolute stereochemical configuration, is a hot research objective in CPL-SOMs.[13d,20] In 
this sense, the achievement of a full inversion in the maximum glum value, from +0.001 to 
−0.001 and vice versa, by changing only the heteroatoms (nitrogens vs. oxygens) linking the 
involved BODIPY units to the central chiral spacer, constitutes a new, unexplored, and 
synthetically simple way to efficiently reverse the circular handedness in BODIPY-based 
CPL-SOMs.
To get a deeper insight in this intriguing feature, we optimized computationally the first 
locally excited state (LES) of the studied CPL-SOMs (PCM-CIS/6-31+g*; see SI for 
details). Despite the conformational flexibility of the structures, no remarkable structural 
changes were detected in the computed LESs when compared with the corresponding 
ground states (cf. Figures S4–S5 vs. S6–S7 in SI), as it was suggested by the small Stokes 
shifts exhibited by these CPL-SOMs (see Table S1 and Figure S2 in SI). Indeed, the 
theoretically predicted CPL spectra from such optimized LESs (TD-PCM-B3LYP/6-31+g*; 
see SI for details) did not explain the found CPL reversal. Thus, for oxygenated enantiomers 
2 the predicted CPL spectra (see Figure S6 in SI) fit well with the experimental ones (see 
Figure 2; left plots), but just sign-opposed CPL spectra were predicted for nitrogenated 
enantiomers 1 (cf. Figure 2, right plots, and Figure S7 in SI).
Nonetheless, it should be kept in mind that the fluorescence signatures of BODIPY 
chromophores functionalized with both an efficient-enough electron-donating group and an 
efficient-enough electron-withdrawing group are ruled out by the promotion of an 
intramolecular charge transfer state (ICTS) upon excitation (push-pull effect).[21] On the 
other hand, the different ability of 1 and 2 to promote ICTSs (higher for 1, due to the 
presence of the stronger amino/chlorine push-pull effect) could cause crucial differences in 
the charge distribution upon excitation, which could also explain the observed CPL reversal, 
as well as the fail in the prediction of the CPL signalization in the case of 1.
The claimed promotion of ICTSs in 1 and 2 was experimentally confirmed by diminishing 
its probability by lowering the polarity of the solvent. Thus, changing chloroform by 
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cyclohexane caused an enhancement of the fluorescence quantum yield displayed by these 
molecules (up to ca. 17% and 30% for enantiomers 1 and 2, respectively; see Table S1 in 
SI). The lower fluorescence response of the former (nitrogenated) enantiomers also supports 
that their fluorescence signatures are deeply affected by the promotion of ICTS. However, 
the change in the solvent polarity did not cause any significant difference in the shapes of the 
corresponding absorption and emission spectra, neither in the CD and CPL signalizations, 
nor in the observed glum values. The demonstrated existence of ICTS effects in these CPL-
SOMs is very valuable, because it opens the possibility of tuning the emission efficiency by 
the modulation of the effect through further physical and/or chemical modifications. It must 
be noted here that possible luminescence from the populated ICTSs could contribute to the 
final fluorescence emission (superimposed dual emission from the LES and from the ICTS), 
explaining also the differences found in the shapes of the CPL spectra of 1 and 2 (couplet-
like for the latter; see Figure 2). Nonetheless, it must be also taken into account that the 
shapes of the CPL spectra are highly dependent on small changes in the structure of the 
chiral luminescent system (including small conformational changes).
In summary, we report on the establishment of new and simple structural design for CPL-
SOMs based on haloBODIPY moieties embedded in a helically-labile chiral architecture. In 
such a design, only two accessible precursors are required: a readily accessible 
dihaloBODIPY and flexible enantiopure diamine or diol. The goal of the reported design is 
comprising, all-in-one, synthetic accessibility, capacity for reversing the polarization 
handedness, helical lability and, what is very important, reactive functional groups making 
possible photophysics modulation by known chemical transformations.[22] This combination 
of properties make the new design to be unique as valuable platform for advancing in the 
development of smarter CPL-SOMs for envisaged photonic tools (e.g., fluorescent dyes for 
CPL-based microscopy in physiological media).
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Figure 1. 
Studied CPL-SOMs (only the R,R enantiomers are shown), and known preferential helical 
conformation for (R,R)-1 (right).
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Figure 2. 
CPL (upper curves; R,R enantiomers in normal lines, S,S in dotted lines) and total 
luminescence (lower curves) spectra of 1 (left) and 2 (right) in degassed CHCl3 solution (ca. 
10−3 M) at 295 K, upon exciting the BODIPY chromophores (see SI for details).
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